Osiris Announces Implementation of Prestige Lyotechnology℠ Preservation Method Allowing Ambient Storage of Living Tissues
June 04, 2018 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., June 04, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics,...
Osiris Announces New Peer-Reviewed Publication Summarizing Clinical Outcomes of Viable Cryopreserved Placental Membranes for Management of Chronic Diabetic Foot Ulcers in Real World Setting
April 25, 2018 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., April 25, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics,...
Osiris Therapeutics to Present Clinical and Scientific Studies at Symposium on Advanced Wound Care and Wound Healing Society Spring Conference
April 24, 2018 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Maryland, April 24, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for...
Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO
February 06, 2018 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR) is pleased to announce that its Board of Directors, at a Board Meeting on February 6th, 2018, appointed...
Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation
November 02, 2017 18:45 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR) (the “Company”), a leading regenerative medicine company focused on developing and marketing products for...
Osiris Therapeutics, Inc. Provides Update on Audit of 2015 and 2016 Financial Statements
October 30, 2017 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR) (the “Company”), a leading regenerative medicine company focused on developing and marketing products for...
Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane
October 23, 2017 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care,...
Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology
October 19, 2017 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care,...
Osiris Announces a Peer-Reviewed Publication Reporting the Use of Placental Membranes for Refractory Cutaneous Sinus Tracts of Surgical Origin
October 05, 2017 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Oct. 05, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care,...
Osiris Appoints Linda Palczuk to serve as its President & CEO
June 26, 2017 09:15 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., June 26, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR) is pleased to announce that its Board of Directors has appointed Ms. Linda Palczuk, age 55, to serve as...